Page last updated: 2024-10-31

metoclopramide and Post-Concussion Syndrome

metoclopramide has been researched along with Post-Concussion Syndrome in 1 studies

Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.

Post-Concussion Syndrome: The organic and psychogenic disturbances observed after closed head injuries (HEAD INJURIES, CLOSED). Post-concussion syndrome includes subjective physical complaints (i.e. headache, dizziness), cognitive, emotional, and behavioral changes. These disturbances can be chronic, permanent, or late emerging.

Research Excerpts

ExcerptRelevanceReference
"Metoclopramide was not associated with lower headache risk on propensity score matching [treated vs."1.48No association between metoclopramide treatment in ED and reduced risk of post-concussion headache. ( Aglipay, M; Barlow, K; Barrowman, NJ; Bresee, N; Dubrovsky, AS; Freedman, SB; Gravel, J; Ledoux, AA; Momoli, F; Richer, L; Zemek, R, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bresee, N1
Aglipay, M1
Dubrovsky, AS1
Ledoux, AA1
Momoli, F1
Gravel, J1
Freedman, SB1
Barlow, K1
Richer, L1
Barrowman, NJ1
Zemek, R1

Other Studies

1 other study available for metoclopramide and Post-Concussion Syndrome

ArticleYear
No association between metoclopramide treatment in ED and reduced risk of post-concussion headache.
    The American journal of emergency medicine, 2018, Volume: 36, Issue:12

    Topics: Administration, Intravenous; Adolescent; Canada; Child; Dopamine D2 Receptor Antagonists; Emergency

2018